Kidney pericytes: A novel therapeutic target in interstitial fibrosis

Histology and Histopathology

Volumn 27, Issue 12, 2012, Pages 1503-1514

  Smith, Stuart W ^a   Schrimpf, Claudia ^b,d   Parekh, Dipen J ^c   Venkatachalam, Manjeri ^c   Duffield, Jeremy S ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angiogenesis; CD248; Kidney fibrosis; Pericytes; Vasculature

Indexed keywords

CD248 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TUMOR ANTIGEN;

ANIMAL; BIOLOGICAL MODEL; CHRONIC KIDNEY FAILURE; DISEASE MODEL; DRUG ANTAGONISM; FIBROSIS; GENE SILENCING; GENETICS; HUMAN; KIDNEY; MICROVASCULATURE; MOUSE; MYOFIBROBLAST; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PERICYTE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, NEOPLASM; DISEASE MODELS, ANIMAL; FIBROSIS; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY; MICE; MICROVESSELS; MODELS, BIOLOGICAL; MYOFIBROBLASTS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION;

MURINAE;

EID: 84871036391     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Armulik A., Abramsson A. and Betsholtz C. (2005). Endothelial/pericyte interactions. Circ. Res. 97, 512-523.
2. Armulik A., Genove G., Mae M., Nisancioglu M.H., Wallgard E., Niaudet C., He L., Norlin J., Lindblom P., Strittmatter K., Johansson B.R. and C. Betsholtz. (2010). Pericytes regulate the blood-brain barrier. Nature 468, 557-561.
3. Asada N., Takase M., Nakamura J., Oguchi A., Asada M., Suzuki N., Yamamura K., Nagoshi N., Shibata S., Rao T.N., Fehling H.J., Fukatsu A., Minegishi N., Kita T., Kimura T., Okano H., Yamamoto M. and Yanagita M. (2011). Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J. Clin. Invest. 121, 3981-3990.
4. Baluk P., Morikawa S., Haskell A., Mancuso M. and McDonald D.M. (2003). Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am. J. Pathol. 163, 1801-1815.
5. Bergers G. and Song S. (2005). The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol. 7, 452-464.
6. Bohle A., Mackensen-Haen S. and Wehrmann M. (1996). Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res. 19, 191-195.
7. Carmeliet P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
8. Chan-Ling T., Page M.P., Gardiner T., Baxter L., Rosinova E. and Hughes S. (2004). Desmin Ensheathment Ratio as an Indicator of Vessel Stability: Evidence in Normal Development and in Retinopathy of Prematurity. Am. J. Pathol. 165, 1301-1313.
9. Chen Y.T., Chang F.C., Wu C.F., Chou Y.H., Hsu H.L., Chiang W.C., Shen J., Chen Y.M., Wu K.D., Tsai T.J., Duffield J.S. and Lin S.L. (2011). Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 80, 1170-1181.
10. Chou S.Y., Spitalewitz S., Faubert P.F., Park I.Y. and Porush J.G. (1984). Inner medullary hemodynamics in chronic salt-depleted dogs. Am. J. Physiol. 246, 146-154.
11. Courtoy P.J. and Boyles J. (1983). Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. J. Ultrastruct. Res. 83, 258-273.
12. Crawford C., Kennedy-Lydon T.M., Callaghan H., Sprott C., Simmons R.L., Sawbridge L., Syme H.M., Unwin R.J., Wildman S.S. and Peppiatt-Wildman C.M. (2011). Extracellular nucleotides affect pericyte-mediated regulation of rat in situ vasa recta diameter. Acta Physiol. 202, 241-251.
13. Crisan M., Deasy B., Gavina M., Zheng B., Huard J., Lazzari L. and Peault B. (2008a). Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol. 86, 295-309.
14. Crisan M., Huard J., Zheng B., Sun B., Yap S., Logar A., Giacobino J.P., Casteilla L. and Peault B. (2008b). Purification and culture of human blood vessel-associated progenitor cells. Curr. Protoc. Stem Cell Biol. 2B, 212-213.
15. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., Andriolo G., Sun B., Zheng B., Zhang L., Norotte C., Teng P.N., Traas J., Schugar R., Deasy B.M., Badylak S., Buhring H.J., Giacobino J.P., Lazzari L., Huard J. and Peault B. (2008c). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 3, 301-313.
16. Demoulin J.B. (2010). No PDGF receptor signal in pericytes without endosialin? Cancer Biol. Ther. 9, 916-918.
17. Diaz-Flores L., Gutierrez R., Madrid J.F., Varela H., Valladares F., Acosta E., Martin-Vasallo P. and Diaz-Flores L. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol. Histopathol. 24, 909-969.
18. Dore-Duffy P. and Cleary K. (2011). Morphology and properties of pericytes. Methods Mol. Biol. 686, 49-68.
19. Duffield J.S. and Humphreys B.D. (2011). Origin of new cells in the adult kidney: results from genetic labeling techniques. Kidney Int. 79, 494-501.
20. Eardley K.S., Kubal C., Zehnder D., Quinkler M., Lepenies J., Savage C.O., Howie A.J., Kaur K., Cooper M.S., Adu D. and Cockwell P. (2008). The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int. 74, 495-504.
21. Eremina V., Jefferson J.A., Kowalewska J., Hochster H., Haas M., Weisstuch J., Richardson C., Kopp J.B., Kabir M.G., Backx P.H., Gerber H.P., Ferrara N., Barisoni L., Alpers C.E. and Quaggin S.E. (2008). VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129-1136.
22. Floege J. and Johnson R.J. (1995). Multiple roles for platelet-derived growth factor in renal disease. Miner. Electrolyte Metab. 21, 271-282.
23. Floege J., Eitner F. and Alpers C.E. (2008). A new look at plateletderived growth factor in renal disease. J. Am. Soc. Nephrol. 19, 1223.
24. Greenberg J.I., Shields D.J., Barillas S.G., Acevedo L.M., Murphy E., Huang J., Scheppke L., Stockmann C., Johnson R.S., Angle N. and Cheresh D.A. (2008). A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 456, 809-813.
25. Guillemin, G.J. and Brew B.J. (2004). Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75, 388-397.
26. Hallan S.I., Ritz E., Lydersen S., Romundstad S., Kvenild K. and Orth S.R. (2009). Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD. J. Am. Soc. Nephrol. 20, 1069-1077.
27. Hellberg C., Ostman A. and Heldin C.H. (2010). PDGF and vessel maturation. Recent Results Cancer Res. 180, 103-114.
28. Hellstrom M., Kalen M., Lindahl P., Abramsson A. and Betsholtz C. (1999). Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126, 3047-3055.
29. Hellstrom M., Gerhardt H., Kalen M., Li X., Eriksson U., Wolburg H. and Betsholtz C. (2001). Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543-553.
30. Hewitson T.D. (2009). Renal tubulointerstitial fibrosis: common but never simple. Am. J. Physiol. Renal Physiol. 296, 1239-1244.
31. Hirschi K.K. and D'Amore P.A. (1996). Pericytes in the microvasculature. Cardiovasc. Res. 32, 687-698.
32. Hirschi K.K. and D'Amore P.A. (1997). Control of angiogenesis by the pericyte: molecular mechanisms and significance. EXS 79, 419-428.
33. Humphreys B.D., Lin S.L., Kobayashi A., Hudson T.E., Nowlin B.T., Bonventre J.V., Valerius M.T., McMahon A.P. and Duffield J.S. (2010). Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85-97.
34. Kida Y. and Duffield J.S. (2011). Frontiers in Research: Chronic Kidney Diseases: The pivotal role of pericytes in kidney fibrosis. Clin. Exp. Pharmacol. Physiol. 38, 417-423.
35. Koesters R., Kaissling B., Lehir M., Picard N., Theilig F., Gebhardt R., Glick A.B., Hahnel B., Hosser H., Grone H.J. and Kriz W. (2010). Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am. J. Pathol. 177, 632-643.
36. Kriz W., Kaissling B. and Le Hir M. (2011). Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J. Clin. Invest. 121, 468-474.
37. Lax S., Hou T.Z., Jenkinson E., Salmon M., MacFadyen J.R., Isacke C.M., Anderson G., Cunningham A.F. and Buckley C.D. (2007). CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair. FEBS Lett. 581, 3550-3556.
38. Lax S., Hardie D.L., Wilson A., Douglas M.R., Anderson G., Huso D., Isacke C.M. and Buckley C.D. (2010). The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion. Eur. J. Immunol. 40, 1884-1889.
39. Lerman L.O. and Chade A.R. (2009). Angiogenesis in the kidney: a new therapeutic target? Curr. Opinion Neph. Hyper. 18, 160-165.
40. Levéen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E. and Betsholtz C. (1994). Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887.
41. Li L., Zepeda-Orozco D., Black R. and Lin F. (2010). Autophagy is a component of epithelial cell fate in obstructive uropathy. Am. J. Pathol. 176, 1767-1778.
42. Lin S.L., Kisseleva T., Brenner D.A. and Duffield J.S. (2008). Pericytes and perivascular fibroblasts are the primary source of collagenproducing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617-1627.
43. Lin S.L., Chang F.C., Schrimpf C., Chen Y.T., Wu C.F., Wu V.C., Chiang W.C., Kuhnert F., Kuo C.J., Chen Y.M., Wu K.D., Tsai T.J. and Duffield J.S. (2011). Targeting endothelium-pericyte cross talk by inhi biti ng VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am. J. Pathol. 178, 911-923.
44. Lindblom P., Gerhardt H., Liebner S., Abramsson A., Enge M., Hellstrom M., Backstrom G., Fredriksson S., Landegren U., Nystrom H.C., Bergstrom G., Dejana E., Ostman A., Lindahl P. and Betsholtz C. (2003). Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17, 1835-1840.
45. MacFadyen J.R., Haworth O., Roberston D., Hardie D., Webster M.T., Morris H.R., Panico M., Sutton-Smith M.,. Dell A, van der Geer P., Wienke D., Buckley C.D. and Isacke C.M. (2005). Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett. 579, 2569-2575.
46. MacFadyen J., Savage K., Wienke D. and Isacke C.M. (2007). Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development. Gene Exp. Patterns 7, 363-369.
47. Mayer G. (2011). Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. NDT 26, 1132-1137.
48. Pallone T.L. and Silldorff E.P. (2001). Pericyte regulation of renal medullary blood flow. Exp. Nephrol. 9, 165-170.
49. Quaggin S.E. and Kapus A. (2011). Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int, 80, 41-50.
50. Ribatti D., Nico B. and Crivellato E. (2011). The role of pericytes in angiogenesis. Int. J. Dev. Biol. 55, 261-268.
51. Schrimpf C. and Duffield J.S. (2011). Mechanisms of fibrosis: the role of the pericyte. Curr. Opinion Neph. Hyper. 20, 297-305.
52. Schrimpf C., Xin C., Campanholle G., Gill S., Stallcup W., Lin S., Davis G., Gharib S., Humphreys B.D. and Duffield J.S. (2012). Pericyte TIMP3 and ADAMTS1 Modulate Vascular Stability after Kidney Injury. J Am Soc Nephrol. 23, 863-883.
53. Shepro D. and Morel N.M. (1993). Pericyte physiology. FASEB J. 7, 1031-1038.
54. Simonavicius N., Robertson D., Bax D.A., Jones C., Huijbers I.J. and Isacke C.M. (2008). Endosialin (CD248) is a marker of tumorassociated pericytes in high-grade glioma. Mod. Pathol. 21, 308-315.
55. Smith S.W., Eardley K.S., Croft A.P., Nwosu J., Howie A.J., Cockwell P., Isacke C.M., Buckley C.D. and Savage C.O. (2011). CD248(+) stromal cells are associated with progressive chronic kidney disease. Kidney Int. 80, 199-207.
56. Strutz F. (2008). How many different roads may a cell walk down in order to become a fibroblast? J. Am. Soc. Nephrol. 19, 2246-2248.
57. Strutz F. and Zeisberg M. (2006). Renal Fibroblasts and Myofibroblasts in Chronic Kidney Disease. J. Am. Soc. Nephrol. 17, 2992-2998.
58. Strutz F., Renziehausen A., Dietrich M., Amin J., Becker V., Heeg M., Rastaldi M.P. and Muller G.A. (2001). Cortical fibroblast culture from human biopsies. J. Nephrol. 14, 190-197.
59. Synnestvedt K., Furuta G.T., Comerford K.M., Louis N., Karhausen J., Eltzschig H.K., Hansen K.R., Thompson L.F. and Colgan S.P. (2002). Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993-1002.
60. Tomkowicz B., Rybinski K., Sebeck D., Sass P., Nicolaides N.C., Grasso L. and Zhou Y. (2010). Endosialin/TEM-1/CD248 regulates pericyte proliferation through PDGF receptor signaling. Cancer Biol. Ther. 9, 908-915.
61. Yamagishi S., Yonekura H., Yamamoto Y., Fujimori H., Sakurai S., Tanaka N. and Yamamoto H. (1999). Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab. Invest. 79, 501-509.
62. Zeisberg M. and Duffield J.S. (2010). Resolved: EMT produces fibroblasts in the kidney. J. Am. Soc. Nephrol. 21, 1247-1253.